Market Research Logo

Global TB Diagnostic Market 2015-2019

Global TB Diagnostic Market 2015-2019

About TB Diagnostics

TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio’s analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.Key Geographies

  • Americas
  • APAC
  • EMEA
Key Vendors
  • Abbott
  • Alere
  • Becton, Dickinson
  • F. Hoffmann-La Roche
Other Prominent Vendors
  • Siemens
  • BioMérieux
  • Cepheid
  • Hain Lifescience
  • Hologic
  • Ortho Clinical
  • Epistem UK
  • Eiken Chemical Japan
  • Alere US
Market Driver
  • High Prevalence of TB
  • For a full, detailed list, view our report
Market Challenge
  • Insensitivity of Spear Microscopy
  • For a full, detailed list, view our report
Market Trend
  • Intensification of Rapid Tests in Developing Countries
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio recognizes the following companies as the key players in the Global TB Diagnostic Market: Abbott, Alere, Becton, Dickinson, and Co. and Roche Diagnostics

Other Prominent Vendors in the market are: Siemens, BioMérieux, Cepheid, Hain Lifescience, Hologic, Ortho Clinical, Epistem, Eiken Chemical and Alere US

Commenting on the report, an analyst from Technavio’s team said: “Developments in the diagnostic paradigm and increased allocation of funds and resources have led to the manufacture of new technologies for TB diagnosis. These innovative technologies help to make disease diagnosis rapid and accurate. For instance, the WHO recommends Xpert MTB/RIF for disease diagnosis as the equipment provides improved accuracy and test sensitivity. In 2013, rapid tests were used to diagnose TB in 58% of the 4.9 million individuals with pulmonary TB. Various non-profit organizations are now funding high-burden low-income countries to use these rapid tests. High- and moderate-burden countries, such as South Africa and Brazil, have also intensified their research on molecular diagnostics to develop rapid tests.”

According to the report, the WHO identifies 22 nations, including India, China, and South Africa, as high-burden countries. The high prevalence of the disease has increased the demand for early diagnosis and detection tools. Many countries implement innovative strategies to address market needs, such as public awareness programs and the launch of fast, accurate, and early diagnostics, resulting in a decline in disease incidence rates.

Further, the report states that diagnosing infection and drug-resistant TB is a major factor hindering the market growth.

Companies Mentioned

Abbott, Alere, Becton, Dickinson, F. Hoffmann-La Roche, Siemens, BioMérieux, Cepheid, Hain Lifescience, Hologic, Ortho Clinical, Epistem UK, Eiken Chemical Japan, Alere US

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global TB Diagnostics Market 2014-2019 ($ millions)
    • Five Forces Analysis
  • Prevalence and Incidence Rate
    • Table Incidence Rate per 100,000 Individuals 2013
    • Table High-burden Countries
  • Advances in Technology
    • Second-generation Nucleic Acid Detection
    • Next-generation Nucleic Acid Detection
  • TB Diagnostics Pipeline
    • Table Product Pipeline: TB Diagnostics
  • Market Segmentation by Disease Stage
    • Global Latent TB Diagnostics Market
    • Global Active TB Diagnostics Market
      • Table Segmentation of Global Active TB Diagnostics Market 2014
      • Table Segmentation of Global TB Diagnostics Market by Disease Stage 2014
    • Global Drug Susceptibility Tests Market
  • Geographical Segmentation
    • Table Segmentation of Global TB Diagnostics Market by Geography 2014
    • Global TB Diagnostics Market in APAC
      • India
        • Table India: Revenue Segmentation by Entity 2012
        • Table Public Sector: Segmentation of TB Diagnostics by Revenue 2012
        • Table Private Sector: Segmentation of TB Diagnostics by Revenue 2012
    • Global TB Diagnostics Market in Americas
      • Brazil
        • Table Brazil: Revenue Segmentation by Entity 2012
        • Table Brazil: Common TB Diagnostic Tests and Their Cost 2012
        • Table Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
    • Global TB Diagnostics Market in EMEA
      • South Africa
        • Table South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
        • Table Diagnostic Tests and Costs by Sectors
        • Table South Africa: Segmentation of TB by Revenue 2012-2013
        • Table South Africa: Volume of Tests in Public Sector 2012-2013
        • Table South Africa: Volume of Tests in Private Sector 2012-2013
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and Their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and Their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2013
      • Abbott Diagnostics
        • Table Key Takeaways: Abbott Diagnostics
      • Alere
        • Table Key Takeaways: Alere
      • BD
        • Table Key Takeaways: BD
      • Roche Diagnostics
        • Table Key Takeaways: Roche Diagnostics
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Abbott Diagnostics
      • Key Facts
      • Business Overview
      • Geographical Presence
        • Table Abbott Diagnostics: Geographical Presence
      • SWOT Analysis
    • Alere
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Alere: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
      • Geographical Segmentation by Revenue 2013
        • Table Alere: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • BD
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Product Categorization of BD
      • Revenue Segmentation by Business
        • Table Revenue Segmentation of BD 2013
      • Segmental Revenue Comparison 2013 and 2012
        • Table Revenue Comparison ($ millions)
      • Revenue Segmentation by Geography
        • Table Revenue Segmentation of BD by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Roche Diagnostics
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Roche Diagnostics: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
      • Geographical Segmentation by Revenue 2014
        • Table Roche Diagnostics: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
  • Other Reports in This Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report